席夫碱金属配合物

席夫碱金属配合物
席夫碱金属配合物

Binucleating Ligands:Synthesis of Acyclic Achiral and Chiral Schiff Base-Pyridine and Schiff Base-Phosphine Ligands

Fung Lam,Jia Xi Xu,and Kin Shing Chan*

Department of Chemistry,The Chinese University of Hong Kong,Shatin,Hong Kong

Received May31,1996X

5-tert-Butyl-3-(2′-pyridyl)salicyaldehyde and5-tert-butyl-3-(diphenylphosphino)salicyaldehyde were synthesized from4-tert-butylphenol in good overall yields.Condensation of the salicyaldehydes with2,3-diamino-2,3-dimethylbutane afforded the desired dinucleating Schiff base-pyridine and Schiff base-phosphine ligands,respectively.5-tert-Butyl-3-(2′-pyridyl)salicyaldehyde reacted with optically active1,2-diaminocyclohexanes to give chiral dinucleating Schiff base-pyridine ligands.

Introduction

The synthesis of dinucleating ligands capable of bind-

ing metal ions in close proximity has continued to arouse

interest among chemists.Since1970,1,2the preparation

of dinucleating ligands plays a central role in bimetallic

chemistry which is currently the area of extensive

investigation due to its importance in the fields of

bioinorganic chemistry,homogeneous catalysis,and mag-

netic exchange processes.3The design of dinucleating

system determines the nature of metal ions to be incor-

porated,coordination environment,and metal-metal separation of the bimetallic complexes.Several kinds of dinucleating ligands have been reported1,2to afford binuclear complexes.Previous efforts have been focused on the synthesis and complexation of a vast array of symmetrical dinucleating macrocycles due to the relative ease of their synthesis.4However,this kind of ligand is usually more useful in the preparation of homobimetallic complexes while the synthesis of heterobimetallic com-plexes is better accomplished by using the heteroditopic ligands.5An important category of the heteroditopic ligands is the Schiff base-crown ether macrocyclic com-pounds.6The Schiff base-crown ether ligands have been demonstrated to complex soft and hard metal ions in their soft(Schiff base)and hard(crown ether)cavities.Another type is the acyclic Schiff base-carboxylic acids which were reported to complex soft and hard metal ions selectively.7While the aforementioned heteroditopic ligands bear hard binding sites coupled to the Schiff base moieties,here we report the synthesis of achiral and chiral acyclic side-off Schiff base-pyridine and Schiff base-phosphine ligands containing the relatively softer pyridyl and phosphino groups which may allow complex-ation of low valent transition metal ions.8The general structure of the dinucleating ligands is shown in Figure 1.

As shown in Figure1,in these phenolic bridged dinucleating ligands,the Schiff base moieties provide the internal salen type N2O2cavity while the functional groups X serve as the extra binding ends to constitute the external O2X2donor set.Schiff base ligands are well known to afford stable transition metal complexes,9and their monometallic chemistry has been extensively stud-ied.10The dinucleating properties of our Schiff base system are attributed to the donor groups X(X) 2-pyridyl or diphenylphosphino)at3′-positions giving rise to the external O2X2binding sites.While the O2N2sites of the pyridyl derivative are expected to bind first row transition metal ions,the O2P2system of the Schiff base-phosphine ligand can complex the softer second and third row transition metal ions as well.11In order to enhance the solubility of the ligands and their bimetallic com-plexes in organic solvents,the lipophilic tert-butyl groups and the tetramethylethylene bridge are introduced in our

X Abstract published in Advance ACS Abstracts,November1,1996.

(1)(a)Casellato,U.;Vigato,P.A.;Vidali,M.Coord.Chem.Rev. 1977,23,31.(b)Casellato,U.;Vigato,P.A.;Fenton,D.E.;Vidali,M. Chem.Soc.Rev.1979,8,199.(c)Lehn,J.M.Pure Appl.Chem.1980, 52,2441.

(2)(a)Zanello,P.;Tamburini,S.;Vigato,P.A.;Mazzocchin,G.A. Coord.Chem.Rev.1987,77,165.(b)Vigato,P.A.;Tamburini,S.; Fenton,D.E.Coord.Chem.Rev.1990,106,25.(c)Fraser,C.;Johnston, L.;Rheingold,A.L.;Haggerty,B.S.;Williams,G.K.;Whelan,J.; Bosnich,B.Inorg.Chem.1992,31,1835.(d)van Veggel,F.C.J.M.; Verboom,W.;Reinhoudt,D.N.Chem.Rev.1994,94,279.

(3)(a)Fenton,D.E.,in A.G.Sykes(Ed.)Advances in Inorganic and Bioinorganic Mechanisms;Sykes,A.G.,Ed.;Academic Press: London,1983;Vol.2.(b)Karlin,K.D.;Zubieta,J.Biological and Inorganic Copper Chemistry;Adenine Press:Guilderland,NY,1986; Vols.1,2.McKenzie,C.J.;Robson,R.J.Chem.Soc.,https://www.360docs.net/doc/0c1890535.html,mun. 1988,112.(c)Willett,R.D.;Gatteschi,D.;Kahn,O.Magneto-structural Correlations in Exchange Coupled Systems;Nato ASI Series,D.Reidel

Publishing Co.:Dordrecht,1983.

(4)(a)Himmelsbath,M.;Lintvedt,R.L.;Zehetmair,J.K.;Nanny, M.;Heeg,M.G.J.Am.Chem.Soc.1987,109,8003.(b)Nelson,S.M. Pure Appl.Chem.1980,52,2461.(c)Atkins,J.A.;Black,D.;Blake, A.J.;Marin-Becerra,A.;Parsons,S.;Ruiz-Ramirez,L.;Schro¨der,M. J.Chem.Soc.,https://www.360docs.net/doc/0c1890535.html,mun.1996,457.

(5)Lehn,J.M.Pure Appl.Chem.1980,52,2441.

(6)(a)van Veggel,F.C.J.M.;Harkema,S.;Bos,M.;Verboom,W.; van Staveren,C.J.;Gerritsma,G.J.;Reinhoudt,D.N.Inorg.Chem. 1989,28,1133.(b)van Staveren,C.J.;van Eerden,J.;van Veggel,F.

C.J.M.;Harkema,S.;Reinhoudt,

D.N.J.Am.Chem.Soc.1988,110, 4994.(c)van Veggel,F.C.J.M.;Bos,M.;Harkema,S.;Verboom,W.; Reinhoudt,D.N.Angew.Chem.,Int.Ed.Engl.1989,28,746.

(7)(a)Torihara,N.;Okawa,H.;Kida,S.Inorg.Chim.Acta.1976, 26,97.(b)Okawa,H.;Tanaka,M.;Kida,S.Chem.Lett.1974,987.(c) Vidali,M.;Vigato,P.A.;Casellato,U.Inorg.Chim.Acta.1976,17, L5.(d)Okawa,H.;Nishida,Y.;Tanaka,M.;Kida,S.Bull.Chem.Soc. Jpn.1977,50,127.

(8)Lockemeyer,J.R.;Rheingold,A.L.;Bulkowski,J,https://www.360docs.net/doc/0c1890535.html,ano-metallics1993,12,256.

(9)Dabrowska,D.;Rzoska,W.Acta Pol.Pharm.1978,35,69.

(10)Hobday,M.D.;Smith,T.D.Coord.Chem.Rev.1972-73,9, 311.

(11)(a)Dunbar,K.R.;Quilleve′re′,https://www.360docs.net/doc/0c1890535.html,anometallics1993,12,618.

(b)Soulivong,D.;Matt,D.;Ziessel,R.Tetrahedron Lett.1993,34,1151. Figure1.

https://www.360docs.net/doc/0c1890535.html,.Chem.1996,61,8414-8418

S0022-3263(96)01020-1CCC:$12.00?1996American Chemical Society

ligand design.1,2-Diaminocyclohexanes,readliy avail-able chiral diamines,are employed for the synthesis of chiral ligands.

The class of chiral dinucleating ligands is especially

interesting since the asymmetric induction coupled with bimetallic cooperativity in a multiple redox reaction for these heterobimetallic complexes would be promising biomimetics as well as potential asymmetric catalysts such as aerobic oxidation catalysts.12We now disclose our full results in the synthesis of acyclic achiral and chiral Schiff base-pyridine and achiral Schiff base-phosphine ligands.13

Results and Discussion

The dinucleating ligands7and13were prepared by the condensation of2,3-diamino-2,3-dimethylbutane and optically active1,2-diaminocyclohexanes with5-tert-butyl-3-(2′-pyridyl)salicyaldehyde and5-tert-butyl-3-(diphenylphosphino)salicyaldehyde which were synthe-sized according to Schemes1and2.

As shown in Scheme1,the ligand7was synthesized from4-tert-butylphenol in four steps in50%overall yield. Formylation of4-tert-butylphenol with formaldehyde14in the presence of SnCl4afforded the salicyaldehyde2which was then brominated with Br2/AcOH15to give3-bromo-5-tert-butylsalicyaldehyde(3)in95%yield.Stille type palladium-catalyzed cross coupling16of3with2-(tri-n-butylstannyl)pyridine17in THF produced5-tert-butyl-3-(2′-pyridyl)salicyaldehyde(5)in93%yield.Condensation of5with2,3-diamino-2,3-dimethylbutane18afforded the desired dinucleating ligand7in76%yield.

Similarly,ligand13was prepared by the condensation reaction with5-tert-butyl-3-(diphenylphosphino)salicy-aldehyde(11)in six steps starting from4-tert-butylphenol as shown in Scheme2.Bromination of4-tert-butylphenol (1)gave a96%yield of the dibromophenol8which was then methylated with Me2SO4to afford the dibromo-anisole9in94%yield.Lithiation of7with n-BuLi in Et2O at-78°C followed by quenching with PPh2Cl produced(3-bromo-5-tert-butyl-2-anisyl)diphenylphos-phine(10)in75%yield.9was lithiated with n-BuLi/ TMEDA in Et2O at-78°C and was subsequently quenched with anhydrous DMF to afford the o-methoxy-benzaldehyde11in70%yield.Without the addition of TMEDA,no aldehyde11was formed even though the lithiation was succcessful as evidenced by the formation of deuteriated arene upon trapping reaction with D2O. Demethylation of11with BBr3yielded the salicyaldehyde 11in80%yield which was then condensed with2,3-diamino-2,3-dimethylbutane to afford ligand13in70% yield.

The enantiomeric pair of chiral acyclic pyridine ligands was prepared via the condensation of5-tert-butyl-3-(2′-pyridyl)salicyaldehyde(5)with either(R,R)-and(S,S)-1,2-diaminocyclohexanes in the form of mono(+)-tar-trates19in85and86%yield,respectively(Scheme3).16 and17showed equal but opposite sign of optical rotation confirming their enantiomeric relationship.

The characteristic functionalities of Schiff base ligands include the hydrogen bonded hydroxyl groups and the azomethine groups(-C d N-).These functional groups were identified in7,13,16,and17by comparing the spectroscopic data with literature values of similar systems.1a,6Broad peaks were observed in the range 3600-2400cm-1in their IR spectra which strongly suggested the presence of hydrogen bonded OH groups. Low field broad singlets appeared atδ14.76,14.37,14.14, and14.14in the1H NMR spectra of7,13,16,and17 respectively,and supported hydrogen bonded phenolic protons.In the IR spectra of these compounds,strong

(12)For leading references:Larrow,J.F.;Jacobsen,E.N.J.Am. Chem.Soc.1994,116,12919.

(13)Lam,F.;Chan,K.S.Tetrahedron Lett.1996,35,2439.

(14)Casiraghi,G.;Casnati,G.;Puglia,G.;Sartori,G.;Terenghi,G. J.Chem.Soc.Perkin Trans.11980,1862.

(15)Wriede,U.;Fernandez,M.;West,K.F.;Harcourt,D.;Moore,

https://www.360docs.net/doc/0c1890535.html,.Chem.1987,52,4485.

(16)Stille,J.K.Angew.Chem.,Int.Ed.Engl.1986,25,508.

(17)Jutzi,P.;Gilge,https://www.360docs.net/doc/0c1890535.html,anomet.Chem.1983,246,163.

(18)Sayre,R.J.Am.Chem.Soc.1955,77,6899.

(19)Larrow,J.F.;Jacobsen,E.N.Gao,Y.;Hong,Y.;Nie,X.;Zepp,

https://www.360docs.net/doc/0c1890535.html,.Chem.1994,59,1939.

Scheme1Scheme2

Binucleating Ligands https://www.360docs.net/doc/0c1890535.html,.Chem.,Vol.61,No.24,19968415

signals at1620-1630cm-1were observed and likely arose from the C d N stretch of the imine linkage.The singlets atδ8.3-8.4in their NMR spectra,indicating the presence of azomethine protons,20substantiated the IR assignment.

Compounds7and13also exhibited characteristic UV-vis spectra of Schiff base ligands.Schiff base ligands exhibit two absorption peaks at a lower energy region (>300nm).Bosnich21has made general assignments of the electronic transitions.The stronger,higher energy peak is attributed to theπfπ*transition of the azomethine chromophore while the weaker and less energetic peak is assigned to the n fπ*transition involving the promotion of the lone pair electron of azomethine nitrogen atom to the antibondingπorbital associated with the azomethine group.Both7and13 exhibited a pair of absorption bands in their electronic spectra.The strong peak at340-350nm and the less intense peak at430-440nm corresponded well to the expectedπfπ*and n fπ*transitions of Schiff base derivatives.

Preliminary studies showed that both ligands16and 17formed mononuclear metal complexes with copper and nickel ions in high yields(Scheme4).Both homo and hetero binuclear complexes were prepared,and the full characterization by X ray crystallography as well as their catalytic activity are in progress.

Conclusion

In conclusion,we have synthesized acyclic chiral and achiral dinucleating ligands of Schiff bases of pyridine and phosphine groups.Preliminary complexation studies show that these ligands formed heterobimetallic com-plexes with Ni and Cu.22Further studies of the bi-metallic chemistry of these ligands are in progress.

Experimental Section

UV-vis spectra were recorded using CH2Cl2as the solvent. IR spectra were recorded on a FT-IR spectrophotometer as neat film on KBr plates.1H NMR spectra were recorded either at250MHz.Chemical shifts(δ)were reported in ppm downfield from internal standard tetramethylsilane,and coupling constants(J)were reported in hertz.13C Spectra were obtained at62.9or125MHz.Mass spectra(EI)were obtained at70eV,and FABMS was recorded using m-nitrobenzyl alcohol(NBA)as the matrix at National Tsing Hua University,Taiwan.Elemental analyses were performed by the Medac Ltd,Department of Chemistry,Brunel University, United Kingdom.Specific rotation were determined on a polarimeter.

Unless otherwise noted,all materials were obtained from commercial suppliers and used without further purification. 2-(Tributylstannyl)pyridine(4),172,3-diamino-2,3-dimethyl-butane(6),182,6-dibromo-4-tert-butylphenol(8),232,6-dibromo-4-tert-butylanisole(9),24(R,R)-1,2-diammoniocyclohexane mono-(+)-tartrate,19and(S,S)-1,2-diammoniocyclohexane mono-(-)-tartrate salt(5)19were prepared according to the literature methods.Tetrahydrofuran(THF)and diethyl ether were distilled from sodium benzophenone ketyl immediately prior to use.Hexane was distilled over calcium chloride,and toluene was distilled from sodium.Silica gel(70-230mesh)was used for column chromatography.Thin layer chromatography was performed on Merck precoated silica gel60F254plates.All melting points were uncorrected.

3-Bromo-5-tert-butyl-2-hydroxybenzaldehyde(3).To a solution of219(0.52g,2.93mmol)and sodium acetate(0.44 g,5.37mmol)in glacial acetic acid(13mL),was added bromine

(0.47g,2.93mmol)in acetic acid(5mL)dropwise within0.5

h.The mixture was heated at50°C for12h.The solvent was removed in vacuo,and the residue was poured into water and then extracted with dichloromethane.The organic layer was washed with Na2S2O5and NaHCO3solution and dried (MgSO4).The solvent was removed,and the crude product was purified by column chromatography using hexane/ethyl acetate(5:1)as the eluent(R f)0.70)to give pale yellow solids of15(0.71g,95%):mp81-83°C(CH2Cl2/hexane);1H NMR (CDCl3,250MHz)δ1.30(s,9H),7.48(d,1H,J)2.2Hz), 7.79(d,1H,J)2.2Hz),9.82(s,1H),11.39(s,1H);mass spectrum m/e(%relative intensity)258(M++2,35),256(M+, 35),243(100),241(100);IR(film)3600-3200,2958,1656, 1456,736,724cm-1.Anal.Calcd for C11H13BrO2:C,51.38; H,5.10.Found:C,51.20;H,5.08.

3-(2′-Pyridyl)-5-tert-butyl-2-hydroxybenzaldehyde(5). Salicyaldehyde3(0.040g,0.156mmol),2-(tri-n-butylstannyl)-pyridine(0.17g,0.468mmol),and Pd(PPh3)4(0.018g,0.0156 mmol)were dissolved in anhydrous THF(5mL).The mixture was degassed by the freeze-thaw-pump method(three cycles)

(20)Alyea,E.C.;Malek,A.Can.J.Chem.1975,53,939.

(21)Bosnich,B.J.Am.Chem.Soc.1968,90,627.

(22)Lam,F.;Wang,R.-J.;Mak,T.C.W.;Chan,K.S.J.Chem.Soc., https://www.360docs.net/doc/0c1890535.html,mun.1994,2439.

(23)Kajigaeshi,S.;Kakinimi,T.;Tokiyama,H.;Hirakawa,T.; Okamoto,T.Chem.Lett.1987,627.

(24)Koike,K.;Murata,K.;Kosugi,K.Chem.Abstr.1991,114, 101336s.

Scheme3Scheme4

https://www.360docs.net/doc/0c1890535.html,.Chem.,Vol.61,No.24,1996Lam et al.

and then heated at100°C under nitrogen for72h.The solvent was removed at reduced pressure,and the residue was purified by column chromatography using hexane/ethyl acetate (10:1)as the eluent to give yellow solids(R f)0.20)as the product(0.037g,93%):mp89-91°C(CH2Cl2/hexane);1H NMR(CDCl3,250MHz)δ1.37(s,9H),7.30(m,1H),7.89 (td,1H,J)1.8,8.3Hz),7.90(d,1H,J)2.5Hz),7.99(d,1 H,J)8.3Hz),8.09(d,1H,J)2.5Hz),8.56(d,1H,J)4.3 Hz),10.60(s,1H)15.09(bs,1H);13C NMR(CDCl3,62.9MHz)δ31.30,34.24,119.57,120.10,122.01,124.25,127.13,129.75, 137.93,140.05,145.89,157.00,161.20,190.80;mass spectrum m/e(%relative intensity)255(M+,8),240(22),227(100),212 (56);IR(film)3600-2400,1680,1597,1480,1255cm-1.Anal. Calcd for C16H17NO2:C,75.27;H,6.71;N,5.49.Found:C, 74.89;H,6.60;N,5.42.

Bis[5′-tert-butyl-3′-(2′′-pyridyl)salicylidene]-1,1,2,2-tet-ramethylethylenediamine(7).To a solution of5(0.042g, 0.165mmol)in refluxing absolute ethanol(5mL)was added slowly in20min2,3-diamino-2,3-dimethylbutane(6)(0.0096 g,0.083mmol)in absolute ethanol(5mL)to yield a yellow solution.The solution was refluxed for1h.After cooling, yellow crystals were collected by filtration.The rest of product was obtained by cooling the filtrate at0°C for several hours followed by filtration to afford totally0.037g of bright yellow solids as the product(76%):mp218-220°C(ethanol);1H NMR(CDCl3,250MHz)δ1.35(s,18H),1.41(s,12H),7.15-7.20(m,2H),7.33(d,2H,J)2.5Hz),7.69(td,2H,J)1.9,

7.5Hz),7.96(d,2H,J)2.5Hz),8.05(d,2H,J)8.3Hz),

8.44(s,2H),8.68(d,2H,J)4.3Hz),14.76(bs,2H);13C NMR(CDCl3,62.9MHz)δ23.63,32.14,34.77,65.82,119.67, 122.15,125.31,127.66,129.86,131.51,136.45,141.57,149.81, 156.65,158.57,162.48;mass spectrum m/e(%relative inten-sity)590(M+,11);IR(film)3600-2400,2962,1628,1598, 1469,1257cm-1;UV-vis[λmax,nm( ,L mol-1cm-1)]342(21.5×103),434(1.65×103).Anal.Calcd for C38H46N4O2?1/2H2O: C,76.09;H,7.90;N,9.34.Found:C,76.13;H,7.85;N,9.35.

(3-Bromo-5-tert-butyl-2-methoxyphenyl)diphenylphos-phine(10).To a solution of924(5.01g,15.6mmol)in anhydrous ether(20mL)under nitrogen-78°C was added n-BuLi(1.6M,10mL,16.0mmol)dropwise.The mixture was stirred for0.5h at-78°C to give a yellow solution to which PPh2Cl(3.44g,15.6mol)in anhydrous ether(10mL)was added dropwise at-78°C under nitrogen.The solution was allowed to warm up to room temperature and stirred for2h. Dilute HCl(10mL)was added to the solution at5°C.The mixture was extracted with ether,and the organic layer was collected and dried over MgSO4.After removal of solvent,a pale yellow oil was obtained.White crystals were collected by crystallization from ethanol,and the crude product from the mother liquor was purified by column chromatography using hexane/ethyl acetate(10:1)as the eluent(R f)0.70)to give totally5.0g of10(75%):mp101-103°C(CH2C2/hexane); 1H NMR(CDCl3,250MHz)δ1.08(s,9H),3,77(s,3H),6.64 (dd,1H,J)2.5,4.2Hz),7.20-7.36(m,10H),7.50(d,1H, J)2.5Hz);mass spectrum m/e(%relative intensity)428 (M++2,98),426(M+,100).IR(film)3069,2962,1474,1267 cm-1.Anal.Calcd for C23H24BrOP:C,64.65;H, 5.66. Found:C,64.95;H,5.69.

5-tert-Butyl-3-(diphenylphosphino)-2-methoxybenzal-dehyde(11).To a well-stirred solution of10(2.94g,6.9 mmol)and TMEDA(1.04g,9.0mmol)in anhydrous ether(10 mL)at-78°C was added n-BuLi(1.6M,4.4mL,7.0mmol) dropwise under nitrogen.The orange solution was stirred at -78°C for1h.Distilled DMF(2.52g,34.5mmol)was added to the solution via a syringe at-78°C under nitrogen.The mixture was allowed to warm up to room temperature and stirred for2h.Dilute HCl was slowly added to the reaction mixture until pH)2.After stirring for1-2h,the mixture was extracted with dichloromethane,and the organic layer was dried(Na2SO4)to afford yellow oil after removal of solvent. The crude product was purified by column chromatography (hexane/ethyl acetate)10:1)to give white solids of22(1.82 g,70%):R f)0.55;mp125-126°C(CH2Cl2/hexane);1H NMR (CDCl3,250MHz)δ1.10(s,9H),3.86(s,3H),7.01(m,1H), 7.24-7.35(m,10H),7.82(d,1H,J)2.3Hz),10.35(s,1H); MS m/e(relative intensity)376(M+,88),348(97),185(14);IR(film)2963,1687,1586,1247cm-1.Anal.Calcd for C24H25O2P:C,76.58;H,6.69.Found:C,76.61;H,6.73.

5-tert-Butyl-3-(diphenylphosphino)-2-hydroxybenzal-dehyde(12).To a solution of11(0.83g, 2.2mmol)in anhydrous CH2Cl2(20mL)at-78°C under nitrogen,was added slowly BBr3(2.8g,11mmol)in anhydrous CH2Cl2(20 mL)via a syringe.The yellow solution was stirred at-78°C under nitrogen for2h and allowed to stir for further10h at room temperature.The mixture was added to ice-water and extracted with CH2Cl2.The aqueous layer was neutralized by saturated NaHCO3and extracted with CH2Cl2.The dichlo-romethane extract was dried over Na2SO4to give a yellow oil which was purified by column chromatography(hexane-ethyl acetate10:1)to afford a pale yellow solid(0.63g,80%):R f) 0.60;mp110-112°C(CH2Cl2/hexane);1H NMR(CDCl3,250 MHz)δ1.28(s,9H),7.06(dd,1H,J)2.5,4.8Hz),7.37(m, 10H),7.54(d,1H,J)2.5Hz),9.90(s,1H),11.43(d,1H,J )2.8Hz);13C NMR(CDCl3,62.9MHz)δ30.87,33.99,119.34, 122.47,125.62(d,J CP)25.2Hz),127.53,128.48(d,J CP)6.9 Hz),128.72(d,J CP)22.0Hz),130.72(d,J CP)14.5Hz),133.81 (d,J CP)20.8Hz),135.79(d,J CP)11.3Hz),138.94,172.77, 161.13(d,J CP)17.0Hz),199.80;mass spectrum m/e(relative intensity)362(M+,36),334(100);calcd for C23H23O2P:362.1436; found:362.1410;IR(film)3600-3200,2963,1651cm-1.

Bis[5′-tert-butyl-3′-(diphenylphosphino)salicylidene]-1,1,2,2-tetramethylethylenediamine(13).To a solution of 12(0.20g,0.55mmol)in refluxing absolute ethanol(10mL), was added slowly in20min2,3-diamino-2,3-dimethylbutane (6)(0.033g,0.28mmol)in absolute ethanol(10mL)to yield a yellow solution.The ethanolic solution was refluxed for4h. After cooling,yellow crystals were collected after filtration to afford13(0.155g,70%):mp186-189°C(ethanol);1H NMR (CDCl3,250MHz)δ1.07(s,18H),1.34(s,12H),6.76(dd,2 H,J)2.5,4.5Hz),7.19(d,2H,J)2.0Hz),7.32(m,20H), 8.31(s,2H),14.37(bs,2H);13C NMR(CDCl3,62.9MHz)δ23.19,31.17,33.98,65.21,117.16,124.20(d,J CP)13.2Hz), 128.32(m),129.25,133.83(d,J CP)19.5Hz),134.60,136.99 (d,J CP)11.3Hz),140.81,162.11(m);FABMS m/e(%relative intensity)805(M+1+,85);IR(film)3600-2400,2962,1625, 1598,1435cm-1;UV-vis[λmax,nm( ,L mol-1cm-1)]340(7.77×103),436(1.15×103).Anal.Calcd for C52H58N2O2P2.3/ 2

H2O:C,75.07;H,7.39;N,3.37.Found:C,75.06;H,7.31; N,3.25.

Bis[5′-tert-butyl-3′-(2′′-pyridyl)salicylidene]-(R,R)-1,2-cyclohexanediamine(16).(R,R)-1,2-Diammoniocyclohexane mono-(+)-tartrate19(0.132g,0.5mmol),K2CO3(0.138g,1.0 mmol),and distilled water(0.7mL)were stirred together to form a solution,and then ethanol(2.7mL)was added.The resulting mixture was heated to reflux,and a solution of aldehyde5(0.132g,0.5mmol)in ethanol(1.3mL)was added dropwise.The funnel was rinsed with ethanol(0.2mL),and the yellow solution was stirred at refluxed for4h.Water(0.7 mL)was added,and the stirred mixture was cooled to rt.The mixture was extracted with CH2Cl2.The extracted mixture was washed with water(2×1.5mL)and brine(1.5mL).After drying over Na2SO4,the solvent was removed under vaccum, and the residue was recrystallized from hexane to give yellow solids(0.25g,85%yield):mp170-1°C,(phase change118-119°C).R f)0.32(hexane/ethyl acetate)5:1);1H NMR (CDCl3,250MHz)δ1.29(s,18H),1.40-2.10(m,8H),3.33 (m,2H),7.22(dd,2H,J)5.2,7.0Hz),7.26(d,2H,J)2.5 Hz),7.73(ddd,2H,J)1.8,7.0,and7.8Hz),7.85(d,2H,J )2.5Hz),7.96(d,2H,J)7.8Hz),8.38(s,2H),8.71(d,2H, J)5.2Hz),14.14(bs,2H);13C NMR(125MHz,CDCl3),24.19, 31.38,33.13,34.05,72.59,118.91,121.56,124.44,126.60, 128.97,130.59,135.82,141.13,149.21,156.10,156.93,164.87; mass spectrum,m/e(%relative intensity),588(M+,32),334 (70),294(5),254(100),212(9),IR(neat film),733,796,1256, 1451,1565,1596,1629,1633,2862,2936,2960,2400-3600 cm-1.[R]20D)-518°(c)1.0,CH2Cl2);UV-vis[λmax,nm(L mol-1cm-1)]342(16.6×103).Anal.Calcd for C38H44N4O2: C,77.52;H,7.53;N,9.52.Found:C,77.38,H,7.56;N,9.46.

Bis[5′-tert-butyl-3′-(2′′-pyridyl)salicylidene]-(S,S)-1,2-cyclohexanediamine(17).(S,S)-1,2-Diammoniocyclohexane mono-(-)-tartrate19(0.132g,0.5mmol),K2CO3(0.138g,1.0 mmol),and distilled water(0.7mL)were stirred until dissolu-

Binucleating Ligands https://www.360docs.net/doc/0c1890535.html,.Chem.,Vol.61,No.24,19968417

tion was achieved,and then ethanol(2.7mL)was added.The resulting mixture was heated to reflux,and a solution of aldehyde5(0.132g,0.5mmol)in ethanol(1.1mL)was added dropwise.The funnel was rinsed with ethanol(0.2mL),and the yellow solution was stirred at reflux for4h before heating was discontinued.Water(0.7mL)was added,and the stirred mixture was cooled to rt.The mixture was extracted with CH2Cl2.Then the extracted mixture was washed with water (2×1.5mL)and brine(1.5mL)and dried over Na2SO4.The solvent was removed under vaccum,and the residue was recrystallized in hexane to give the yellow solid(0.253g,86% yield):mp169-70°C(phase change118-119°C);R f)0.32 (hexane/ethyl acetate:5:1);1H NMR(CDCl3,250MHz): 1.29 (s,18H),1.40-2.10(m,8H),3.33(m,2H),7.22(d,2H,J) 5.2,7.0Hz),7.26(d,2H,J)2.5Hz),7.73(ddd,2H,J)1.8, 7.0,and7.8Hz),7.85(d,2H,J)2.5Hz),7.96(d,2H,J) 7.8Hz),8.38(s,2H),8.71(d,2H,J)5.2Hz),14.14(bs,2H); 13C NMR(125MHz,CDCl3),24.20,31.38,33.14,34.05,72.59, 118.91,121.57,124.44,126.60,128.97,130.60,135.83,141.14, 149.21,156.10,156.93,164.88;mass spectrum,m/e(%relative intensity),588(M+,22),334(73),294(9),254(100),212(11); IR(neat film)734,796,1256,1451,1565,1596,1630,1634, 2935,2960,2400-3600cm-1;[R]20D)+517°(c)1.0,CH2Cl2); UV-vis[λmax,nm(L mol-1cm-1)]342(16.1×103).Anal.Calcd for C38H44N4O2:C,77.52;H,7.53;N,9.52.Found:C,76.04, H,7.64;N,9.22.

Copper(II)Bis[5′-tert-butyl-3′-(2′′-pyridyl)salicylidene]-(R,R)-1,2-cyclohexanediamine(18).To a refluxing solution of(R,R)Schiff base16(50mg,0.085mmol)in ethanol(10mL) was added dropwise Cu(OAc)2?H2O(17mg,0.085mmol), dissolved in hot ethanol(10mL),within20min.The resulting brown suspension was refluxed for1h.After the mixture was cooled,the precipitate was filtered and recrystallized in CHCl3/ EtOH to give90mg of brown solid(yield81%):mp352-353°C;IR(neat film)2949,2927,1622,1536,1444,1429,1249, 1226,797cm-1;[R]20D)-1.1×103°(c)0.02,CH2Cl2),UV-vis[λmax,nm( ,L mol-1cm-1)]387(21.0×103).Anal.Calcd for C38H42N4O2Cu:C,70.23;H,6.52;N,8.63.Found:C,69.96, H,6.66;N,8.50.HRMS calcd650.2682,found650.2745.

Copper(II)Bis[5′-tert-butyl-3′-(2′′-pyridyl)salicylidene]-(S,S)-1,2-cyclohexanediamine(19).To a refluxing solution of(S,S)Schiff base17(50mg,0.085mmol)in ethanol(10mL) was added dropwise Cu(OAc)2?H2O(17mg,0.085mmol), dissolved in hot ethanol(10mL),within20min.The resulting brown suspension was refluxed for1h.After the mixture was cooled,the precipitate was filtered and recrystallized in CHCl3/ EtOH to give90mg of brown solid(yield81%):mp352-353°C;IR(neat film)2949,2927,1622,1536,1444,1429,1249, 1226,798cm-1.[R]20D)1.1×103o(c)0.02,CH2Cl2),UV-vis [λmax,nm( ,L mol-1cm-1)]388(20.4×103).Anal.Calcd for C38H42N4O2Cu:C,70.23;H,6.52;N,8.63.Found:C,70.29, H,6.52;N,8.63.HRMS calcd650.2682,found650.2705.

Nickel(II)Bis[5′-tert-butyl-3′-(2′′-pyridyl)salicylidene]-(S,S)-1,2-cyclohexanediamine(20).To a refluxing solution of(S,S)Schiff base17(50mg,0.085mmol)in ethanol(10mL) was added dropwise Ni(OAc)2?4H2O(21mg,0.085mmol), dissolved in hot ethanol(10mL),within20min.The yellow precipitate appeared,and the mixture was refluxed for1h. After cooling,the precipitate was filtered and recrystallized in CHCl3/EtOH to give53.4mg of a muddy yellow solid(yield 97%):mp380-381°C;1H NMR(CDCl3,250MHz)1.32(s,18

H),1.62(br,2H),1.76(br,4H),2.36(br,2H),3.24(br,2H),

6.94(dd,2H,J)

7.6,7.8Hz),7.01(dd,2H,J)6.9,7.6Hz),

7.09(s,2H),7.46(s,2H),8.17(d,2H,J)2.2Hz),8.21(d, 2H,J)7.8Hz),8.57(d,2H,J)2.2Hz);IR(neat film)2949, 2927,1622,1537,1445,1251,797cm-1;[R]20D)1.1×103o(c )0.05,CH2Cl2);UV-vis[λmax,nm( ,L mol-1cm-1)]425(13.6×103),329(16.3×103).Calcd for C38H42N4O2Ni:HRMS calcd 645.2739,found645.2743.

Acknowledgment.We thank the Croucher Foun-dation for the award of a studentship to F.L.and the Dow Chemical Co.for financial support.

JO961020F

https://www.360docs.net/doc/0c1890535.html,.Chem.,Vol.61,No.24,1996Lam et al.

氨基酸与水杨醛合成一种手性希夫碱

手性希夫碱的实验合成及理论分析 【摘要】在乙醇溶液和常温条件下,直接缩合水杨醛和氨基乙酸合成了一种手性希夫碱对它进行了抽滤提纯并计算了及其产率,用了显微熔点测定仪测定熔点。 【关键词】氨基酸水杨醛手性希夫碱 1前言 希夫碱是指由含有醛基和氨基的两类物质通过缩水形成含亚胺基(-CH=N-)或甲亚胺基(-RC=N-)的一类有机化合物, 它的基本结构中含有(>C=N-), 是H.Schiff在1864年首先发现的。其杂化轨道上的氮原子上的孤对电子使得希夫碱配体具有极大的灵活性和良好的配位能力, 因而希夫碱金属配合物的研究一直受到广泛的重视。由于氨基酸Schiff碱合成相对容易, 能够选择多种胺类及带有羰基的不同醛和酮进行反应, 其特点是能够灵活地选择反应物,改变取代基给予体原子本性及其位置,可合成许多链状、环合且性能、结构不同的配体。自从六十年代末人们发现过渡金属希夫碱配合物具有生物活性以来,这个领域的研究逐渐活跃起来。希夫碱不仅可以和过渡元素形成配合物,和镧系、锕系及部分主族金属元素也能形成稳定的配合物,此外还有如Zr、Mo、Ru、Ir等贵金属。这些配合物在分析化学、立体化学、电化学、光谱学、分子自组装、超分子化学、生物化学模型系统、催化、材料、核化学化工等学科领域均具有重要意义。 近年来,对手性希夫碱配合物的研究日趋广泛,它的金属配位化合物在生物医药方面由于某些希夫碱具有特殊的生理活性,越来越引起医药界的重视。据报道,氨基酸类、缩氨脲类、缩胺类、杂环类、腙类希夫碱及其应用的配合物具有抑菌、杀菌、抗肿瘤、抗病毒等独特药用效果;催化方面希夫碱及其配合物在催化领域的应用也很广泛,概括而言,希夫碱做催化剂主要是应用于聚合反应,不对称催化环丙烷化反应以及烯烃催化氧化方面和电催化领域。分析化学方面许多希夫碱用来检测、鉴别金属离子,并可借助色谱分析、荧光分析、光度分析等手段达到对某些离子的定量分析;腐蚀方面长期以来,许多金属及其合金在工业、军事、民用等各个领域得到了广泛的应用,但是该金属及其合金在大气中、海水中很不稳定,因此研究寻找有效的缓蚀剂,引起了众多科学家的重视。希夫碱(尤其是一些芳香族的希夫碱)由于含有C=N双键,再加上含有的-OH极易与铜形成稳定的络合物,从而阻止了金属的腐蚀;光致变色方面许多共轭聚合物主链可视为扩展到生色团,它们表现出似燃料的光物理性质,如光致变色、光电导。 N-亚水杨基氨基酸希夫(Schiff) 碱配合物可以作为研究维生素B6酶反应的模型化合物, 具有催化氨基转移和外消旋作用[ 1~3], 并具有良好的抗癌、抗菌活性[ 4, 5], 因此受到化学家注意并引起人们的极大兴趣。通过对它们性质的认识有助于揭示维生素B6酶结构上的特点, 加深对其催化氨基转移机理的理解。因此,本文重述设计了L-亮氨酸与水杨醛反应合成一种手性希夫碱,其反应式: HO 甲醇 + HOC

席夫碱金属SOD模型配合物

席夫碱金属SOD模型配合物 李金芳屠淑洁周荫庄* (首都师范大学化学系北京 100037) O的清除表现出一定的活性且明摘要席夫碱为配体的Cu、Zn、Mn等单核、双核配合物对? 2 显高于非席夫碱单核及双核配合物。近年来该领域新化合物的合成、结构表征及构效关系的研究甚为 活跃,对CuZn-SOD、Mn-SOD、Fe-SOD的席夫碱SOD模型配合物的研究已取得进展。本文介绍了 席夫碱金属SOD模型配合物的合成、表征及相关活性的研究进展。 关键词超氧化物歧化酶席夫碱模型配合物生物活性 The Superoxide Dismutase Mimics of Metal Complexes of Schiff-bases Li Jinfang, Tu Shujie, Zhou Yinzhuang* (Department of Chemistry, Capital Normal University, Beijing 100037) Abstract The design and application of the synthesis of low molecular weight metal complexes containing Cu, Zn, Mn etc. as SOD mimics have received considerable attention during the last decades. Large number of the complexes of Cu, Zn, Mn etc with various donor ligands have been characterized as ? O promising models of the enzyme, including Schiff-base ligands.The results showed that the 2 Schiff-base complexes exhibited that the abilities of eliminating ? O are much higher than that of other 2 kinds of complexes. The research progress in the studies of the SOD model complexes with Schiff-base ligands and its biological activities have been introduced in this paper. Key words Superoxide dismutase, Schiff-bases, Mimic complexes, Biological activity 超氧化物歧化酶(SOD)广泛存在于生物体内,是机体清除超氧阴离子自由基的一种重要酶,在维持机体的氧化——抗氧化平衡中起着重要作用。研究表明SOD活力的高低与机体衰老、肿瘤、炎症等疾病有关。由于天然SOD在稳定性、膜穿透性、生物利用度和免疫原性等方面存在一些限制。因此,对具有SOD活性且能在生理条件下保持稳定的小分子模型物的研究成为热点。当前报道的SOD模型物多为苯并咪唑类、氨羧类、氨基酸及席夫碱等金属配合物。相对于天然SOD,这些小分子模型物具有分子量小、脂溶性好、膜渗透性强、性质稳定等优点,最有望用于药物筛选。SOD模型化合物的活性优劣,取决于中心金属原子的配位结构与天然SOD活性部位微环境的相似程度,配位结构越相似,活性越强,而与核的多寡无关。含有N、O、S给体的席夫碱配体被广泛应用于生物模型配合物的研究中[1,2]。比较以席夫碱为配体和以非席夫碱为配体的单、双核模型配合物对? O清除表现出的活性,则前者明显高于后者[3]。为此,对以席夫碱为 2 李金芳女,24岁,硕士生,现从事功能配合物的研究。*联系人,E-mail: zhouyz7813@https://www.360docs.net/doc/0c1890535.html, 2004-03-18收稿,2005-01-27接受

氨基酸水杨醛席夫碱铜配合物的合成及其表征

氨基酸水杨醛席夫碱铜配合物的合成及其表征 周雨515020910133 一、实验目的 1、了解氨基酸类、席夫碱类化合物及其重要作用 2、掌握制备氨基酸水杨醛席夫碱铜配合物的制备方法,熟悉基本实验操作 3、掌握表征该铜配合物的各种现代仪器分析手段的基本原理以及操作流程 二、实验原理 氨基酸是羧酸链上碳原子的氢被氨基取代之后的化合物,含有氨基和羧基两种官能团,可以根据氨基在碳链上取代的位置分为α-,β-,γ-氨基酸。其中组成蛋白质的大都是α-氨基酸,有20种,除甘氨酸外均是L-α-氨基酸(具有手性)。常用的非手性氨基酸有甘氨酸、β-丙氨酸,这些氨基酸价格低廉因而广泛应用在生化、医药等领域。 水杨醛是邻羟基苯甲醛,广泛应用于有机合成中,是一种常见的工业原料。 席夫碱主要是指含有亚胺或者甲亚胺官能团的化合物,通常由胺和活性羰基化合物发生缩合反应来制备。 席夫碱中的氧原子和氮原子可以与过渡金属形成六元环稳定配合物,其中席夫碱的钴、镍配合物已经作为催化剂在工业上得到应用。同时由于其良好的配位性质,席夫碱可以用于鉴定离子和定量分析离子的含量。 本实验通过使用水杨醛与甘氨酸、β-丙氨酸发生缩合反应生成席夫碱类化合物,席夫碱中含有的氮原子和氧原子和加入的金属铜盐形成稳定的六元环配合物。 合成的金属有机配合物可以通过多种手段进行表征,其中常用的包括通过红外光谱方法、紫外光谱方法鉴定该配合物中含有的官能团,通过XRD表征合成配合物形成的晶体结构,通过核磁分析确定化合物相关信息等。 三、实验仪器和试剂 仪器:核磁共振仪,红外光谱仪,X射线衍射仪,250mL圆底烧瓶,搅拌子,搅拌器,干燥器,胶头滴管,量筒,锥形瓶,pH试纸等。 试剂:氢氧化钾,β-丙氨酸,醋酸铜,蒸馏水,无水乙醇,无水乙醚,溴化钾,氘代氯仿,水杨醛。试剂 均为化学纯级别。 四、实验流程 1、制备流程 配体制备流程: 将3.4g(60mmol)氢氧化钾和5.35g(60mmol)β-氨基酸溶于10mL水,加入250mL烧瓶,将7.3g水杨醛溶于40mL无水乙醇,待两者固体完全溶解后,将水杨醛缓慢滴入体系,溶液变成黄色。在85℃情况下加热回流两小时,点板监测水杨醛反应完后,用100mL无水乙醇稀释旋蒸除去溶剂,得到的黄色固体用甲醇重结晶,过滤得到固体并用二氯甲烷等洗涤固体,干燥。

L-缬氨酸席夫碱金属配合物的合成及光催化性质

2018年3月第26卷第3期一一一一一一一一一工业催化INDUSTRIAL CATALYSIS 一一一一一一一一一一Mar.2018Vol.26一No.3催化剂制备与研究收稿日期:2017-12-14;修回日期:2018-03-03 基金项目:陕西省科技厅基金项目(2016NY -221);陕西省教育厅基金项目(15JK1849;17JS144) 作者简介:刘晓菊,1985年生,女,陕西省榆林市人,硕士,实验师,主要从事有机合成研究三通讯联系人:刘晓菊三L -缬氨酸席夫碱金属配合物的合成及光催化性质 刘晓菊1,2?,李一霄1,陈锦中1,白一瑞1,姚一婷1,马晓燕2 (1.榆林学院化学与化工学院,陕西榆林719000;2.西北工业大学化学工程系,陕西西安710072) 摘一要:以L -缬氨酸和香兰素为起始原料,设计并合成了3种L -缬氨酸席夫碱金属配合物C 13H 20Fe 2+NO 6二C 13H 20Cu 2+NO 6和C 13H 20Sn 2+NO 6,采用1H NMR 二MS (EI )和元素分析等表征其结构三以3种L -缬氨酸席夫碱金属配合物作为光催化剂,研究25?下,C 13H 20Fe 2+NO 6二C 13H 20Cu 2+NO 6和C 13H 20Sn 2+NO 6催化剂在甲醇与水混合溶液中的亚甲基蓝降解性能三结果表明,3种催化剂对亚甲基蓝均有降解活性,其中,C 13H 20Sn 2+NO 6催化剂的亚甲基蓝降降解性能最好,预测这是一类潜在的环保性光催化材料三 关键词:催化化学;L -缬氨酸;金属配合物;光催化性质 doi :10.3969/j.issn.1008-1143.2018.03.004 中图分类号:O643.32;TQ034一一文献标识码:A一一文章编号:1008-1143(2018)03-0018-05 Syntheses and photocatalytic properties of Schiff base metal complexes with L -valine ligand Liu Xiaoju 1,2?,Li Xiao 1,Chen Jinzhong 1,Bai Rui 1,Yao Ting 1,Ma Xiaoyan 2(1.School of Chemistry and Chemical Engineering,Yulin University,Yulin 719000,Shaanxi,China;2.Department of Chemical Engineering,Northwestern Polytechnical University,Xi an 710129,Shaanxi,China)Abstract :Three novel photocatalytic materials(C 13H 20Fe 2+NO 6二C 13H 20Cu 2+NO 6and C 13H 20Sn 2+NO 6)were designed,synthesized with L -valine and vanillin as starting materials and characterized by 1H NMR,MS(EI),elemental analysis and so on.At 25?,the degradation property of MB over the cata-lysts was studied in the mixed solution of methanol and water.The results showed that all of the catalysts had certain degradation activity to MB,respectively.C 13H 20Sn 2+NO 6had the best catalytic activity espe-cially.We forecast they are a kind of environmental friendly photocatalytic materials. Key words :catalytic chemistry;L -valine;metal complex;photocatalytic properties doi :10.3969/j.issn.1008-1143.2018.03.004 CLC number :O643.32;TQ034一一Document code :A一一Article ID :1008-1143(2018)03-0018-05一一氨基酸及其衍生物主要应用于生物活性试剂和 分析化学试剂[1-5]三含多功能基氨基酸希夫碱配体及其金属配合物在结构学二磁学二动力学和反应机 理二配位反应二分析化学二催化二稳定剂染料和颜料以及农业等领域有着重要作用[6-9]三本文以L -缬氨酸和香兰素为原料,合成新型具有手性L -缬氨酸希夫碱配体,配体分别与金属盐FeSO 4四7H 2O二CuSO 4四5H 2O 和SnCl 2四2H 2O 进万方数据

新型吡啶基羧酸席夫碱配体镍配合物的合成和晶体结构_英文_

收稿日期:2010-07-05。收修改稿日期:2010-08-15。 国家自然科学基金资助项目(No .20901004,20971004,20771006)。 * 通讯联系人。E -mail :njwangy@https://www.360docs.net/doc/0c1890535.html, 新型吡啶基羧酸席夫碱配体镍配合物的合成和晶体结构 王 彦*,1,2 王 涛1 汪快兵1 刘光祥1 陈友存1 (1安庆师范学院化学化工学院,安徽省功能配合物重点实验室,安庆 246011) (2南京大学配位化学国家重点实验室,南京210093) 摘要:通过新合成的吡啶基羧酸席夫碱配体(5-(吡啶基-3-亚甲基氨基)间苯二甲酸H 2L ) ,和镍盐反应制备了一个新的镍配合物{[Ni(HL)2(H 2O)2]·2H 2O}n (1),利用元素分析及X -射线单晶衍射对其进行了表征。结构分析结果表明标题化合物属于三斜晶系,P 1空间群,晶胞参数为a =0.76479(11)nm ,b =0.87049(13)nm ,c =1.08113(16)nm ,α=85.583(2)°,β=82.614(2)°,γ=81.565(2)°,V =0.70482(18)nm 3, Z =1,D c =1.586g ·cm -3,μ=0.763mm -1,F (000)=350。在配合物的结构中,Ni 髤的配位构型为畸变的八面体。配合物中每个配体通过羧酸氧和吡啶氮原子和金属配位形成一维链状结构,并通过体系中丰富的氢键作用链接成为三维框架并加以稳定。 关键词:自组装;晶体结构;镍配合物;席夫碱中图分类号:O614.24+2 文献标识码:A 文章编号:1001-4861(2011)01-0193-04 A New Nickel 髤Complex Based on Novel Pyridyl -carboxylate Schiff -Base Ligand:Synthesis and Crystal Structure WANG Yan *,1,2WANG Tao 1WANG Kuai -Bing 1LIU Guang -Xiang 1CHEN You -Cun 1 (1School of Chemistry and Chemical Engineering,Anhui Key Laboratory of Functional Coordination Compounds,Anqing Teachers College,Anqing,Anhui 246011,China )(2State Key Laboratory of Coordination Chemistry,Nanjing University,Nanjing 210093,China ) Abstract:A novel nickel 髤coordination polymer {[Ni (HL)2(H 2O)2]·2H 2O}n (H 2L =5-((pyridin -3-ylmethyl)amino) isophthalic acid)(1)has been synthesized by the reaction of Ni(NO 3)2 ·6H 2O and H 2L under hydrothermal condition.The structure of 1was determined by single -crystal X -ray https://www.360docs.net/doc/0c1890535.html,plex 1crystallizes in triclinic space group P 1with a =0.76479(11)nm,b =0.87049(13)nm,c =1.08113(16)nm,α=85.583(2)°,β=82.614(2)°,γ=81.565(2)°,V = 0.70482(18)nm 3,Z =1,D c =1.586g ·cm -3,μ=0.763mm -1and F (000)=350.The coordination environment of Ni 髤is octahedral,and each ligand links two Ni 髤atoms using its pyridyl N atom and carboxylate O atom to generate an infinite one -dimensional (1D)chain structure.The 1D chains are further connected by hydrogen bonds to give a three dimensional https://www.360docs.net/doc/0c1890535.html,DC:769438. Key words:self -assembly;crystal structure;nickel 髤complex;Schiff -base ligand During the past decade,many chemists have focused their efforts on the synthesis and investigation of highly organized metal -organic frameworks (MOFs)due to their fantastic structural diversities [1-2]as well as potential applications in many areas including gas storage [3],anion exchange [4],catalysis [5]and so on [6-7].Up to now,multidentate N -or O -donor ligands have been widely used and many MOFs have been constructed by 第27卷第1期2011年1月Vol .27No .1193-196 无机化学学报 CHINESE JOURNAL OF INORGANIC CHEMISTRY

席夫碱的性质

席夫碱目录 概述 应用医药方面 催化方面 分析化学 腐蚀方面 光致变色方面 展开概述 应用医药方面 催化方面 分析化学 腐蚀方面 光致变色方面 展开编辑本段概述席夫碱结构通式 英文名:Schiff's base 也称西佛碱 席夫碱主要是指含有亚胺或甲亚胺特性基团(-RC=N-)的一类有机化合物,通常希夫碱是由胺和活性羰基缩合而成。具有优良液晶特性。用作有机合成试剂和液晶材料。 C=N键长约0.124~0.128nm,偶极矩约0.90D。有顺(Z)-、(E)-两种构型。亚胺是由醛或酮与氨或胺缩合而成的,又可分为醛亚胺和酮亚胺。亚胺基是极活泼的基团。与氰氢酸反应生成α-氨基酸,与丙二酸二乙酯反应生成β-氨基酸,还原反应生成胺,与格利雅试剂反应生成胺的衍生物,水解生成醛或酮和胺。 醛酮与伯胺(RNH2)生成含碳氮双键的亚胺: R2C=O + R'NH2 ——R2C=NR' + H2O R、R’都是脂肪族烃基的亚胺不稳定。R、R’其中一个为芳基的亚胺为稳定的晶体,由于平衡偏右,制备相对容易。 编辑本段应用席夫碱类化合物及其金属配合物在医学、催化、分析化学、腐蚀以及光致变色领域的重要应用。在医学领域,席夫碱具有抑菌、杀菌、抗肿瘤、抗病毒的生物活性;在催化领域,席夫碱的钴和镍配合物已经作为催化剂使用;在分析领域,席夫碱作为良好的配体,可以用来鉴别,鉴定金属离子和定量分析金属离子的含量;在腐蚀领域,某些芳香族的希夫碱经常作为铜的缓蚀剂;在光致变色领域,某些含有特性基团的希夫碱也具有独特的应用。医药方面 由于某些席夫碱具有特殊的生理活性,近年来,越来越引起医药界的重视。据报道,氨基酸

铜席夫碱配合物及其制备方法和应用的制作技术

本技术涉及一种铜席夫碱配合物及其制备方法和应用,目的是解决现有的铜席夫碱配合物制备方法中存在的操作繁琐、反应时间长、产率低以及存在安全隐患的技术问题,本技术的一种铜席夫碱配合物,其分子式为[Cu2(HL)2(OAc)2]n,其中HL为肼基(2吡啶基)水杨醛亚胺;本技术铜席夫碱配合物的制备方法,将摩尔比为1:2:2的Cu(OAc)2·H2O、2肼基吡啶和水杨醛,加入含有甲醇的聚四氟乙烯管中,所述Cu(OAc)2·H2O与甲醇的摩尔体积比为0.1:(35)mmol/ml;在80100℃下反应4872h,自然降温,析出黑色棒状晶体,用甲醇溶液洗涤后干燥,即制得所述铜席夫碱配合物。本技术的铜配合物对大肠杆菌、金黄色葡萄球菌及枯草芽孢杆菌具有强的抑菌作用,在生物活性领域有优良的潜在应用前景,可作为新型抗菌剂。 技术要求 1.一种铜席夫碱配合物,其特征在于:所述配合物的分子式为[Cu2(HL)2(OAc)2]n,其中HL为2-{(E)-[2-(2-吡啶基)腙基]甲基}苯氧基,n代表重复单 元数,所述配合物的结构式为: 所述配合物的制备方法包括如下步骤: (1)将摩尔比为1:2:2的Cu(OAc)2·H2O、2-肼基吡啶和水杨醛,加入含有甲醇的聚四氟乙烯管中,所述Cu(OAc)2·H2O与甲醇的摩尔体积比为0.1:3- 5mmol/ml;

(2)将所述聚四氟乙烯管置于不锈钢反应釜中密封,在80-100℃下反应48-72h,自然降温,析出黑色棒状晶体,用甲醇溶液洗涤后干燥,即制得所 述铜席夫碱配合物。 2.根据权利要求1所述的一种铜席夫碱配合物,其特征在于:所述配合物的晶体属单斜晶系,空间群为C2/c,晶胞参数 为:α=90°,β=120.7(6)°,γ= 90°。 3.一种含有权利要求1所述的铜席夫碱配合物的抑菌剂。 技术说明书 一种铜席夫碱配合物及其制备方法和应用 技术领域 本技术涉及一种铜席夫碱配合物及其制备方法和应用。 背景技术 过渡金属配合物由于具有光、电、磁等多种特性,在催化、发光、生物医药等领域表现出广阔的应用前景。现代医学研究表明,铜配合物能够产生抗菌、抗物,因此,席夫碱是合成过渡金属配合物的理想配体。同时,席夫碱化合物大多具有抗肿瘤、抗菌等生物活性,在生化反应中起到转氨基作用,碳氮双键是能力,它形成配合物后由于协同效应,其生物活性比配位前明显增强,其配合物有着广泛的生物活性和抗癌活性,如抗菌,抗真菌,抗肿瘤,抗惊厥,抗炎Jan Reedijk等人报道了将CuCl2·2H2O与肼基-(2-吡啶基)水杨醛亚胺(HL)通过常规溶液反应制得配合物[[Cu(HL)Cl](MeOH)]n,具体而言,首先需要合成肼基-(2 (J.Tang,J.S.Costa,A.Pevec,B. C.Massera,O.Roubeau,I.Mutikainen,U.Turpeinen,P.Gamez,J.Reedijk,Cryst.Growth Des.2008,8,1005-1012.)。在此技术内容 本技术的目的是解决现有的铜席夫碱配合物制备方法中存在的操作繁琐、反应时间长、产率低以及存在安全隐患的技术问题,提供一种可以作为抑菌剂的铜本技术所采用的技术方案是:一种铜席夫碱配合物,所述配合物的分子式为[Cu2(HL)2(OAc)2]n,其中HL为肼基-(2-吡啶基)水杨醛亚胺,n代表重复单元数,所

席夫碱

席夫碱配合物的研究 高级工程人才实验班1507100111 李天赐 席夫碱主要是指含有亚胺或甲亚胺特性基团(-RC=N-)的一类有机化合物,通常席夫碱是由胺和活性羰基缩合而成。席夫碱类化合物及其金属配合物主要在药学、催化、分析化学、腐蚀以及光致变色领域的重要应用。在医学领域,席夫碱具有抑菌、杀菌、抗肿瘤、抗病毒的生物活性;在催化领域,席夫碱的钴、镍和钯的配合物已经作为催化剂使用;在分析化学领域,席夫碱作为良好配体,可以用来鉴别、鉴定金属离子和定量分析金属离子的含量;在腐蚀领域,某些芳香族的席夫碱经常作为铜的缓蚀剂;在光致变色领域,某些含有特性基团的席夫碱也具有独特的应用 催化领域的应用 席夫碱及其配合物在催化领域的应用也很广泛,概括起来说,席夫碱做催化剂主要应用于聚合反应、不对称催化环丙烷化反应以及烯烃催化氧化方面和电催化领域等。 在金属有机物合成领域的应用 金属席夫碱是一类重要的有机配合物,和金属卟啉类似,由于过渡金属配合物可以与小分子(如CO和O2)形成轴向配合物,从而有利于催化反应的进行。金属席夫碱对O2分子的电化学还原具有催化作用. 希夫碱配体在配位化学领域的影响 近几年来希夫碱配合物的研究成为配位化学领域的一大热点,。希夫碱是含活泼羰基化合物和胺、氨基脲、氨基硫脲、醇胺、肼、氨基糖、氨基酚等作用所形成的一类化合物。由于其结构的特殊性,在配位化学中占有重要的地位,是配位化学重点研究的内容之一。由于缩合产物的不同,希夫碱构成了一大类良好配体,其应用范围十分广泛。在一定条件下,希夫碱可以与元素周期表中大部分金属离子形成稳定性不同的金属配合物,这些配合物在诸如立体化学结构、磁性、光谱、动力学和反应机理、生物无机化学原理、生物化学的模拟系统、生物活性、药物化学、分析化学、分子催化等学科领域均具有重要的理论和应用研究意义。 希夫碱的合成 取甘氨酸0.010 mol,溶于适量氢氧化钾一乙醇溶液中,进行搅拌、溶解,然后加入薪蒸水杨醛0,010mol乙醇溶液,搅拌约0,5 h。如有沉淀,则过游得到粗产品如无沉淀,可浓缩溶液或加有机溶剂,使希夫碱析出。反应方程式应为 此合成方法产率可达72 ~83 。粗产品可用乙醇等溶剂进行重结晶,用此方法合成的 希夫碱有: N 一亚水扬基甘氨酸钾.分子式为 CqH日O5NK ·1/4H2O,简写成Sal—GlyK。

席夫碱的反应机理

席夫碱的反应机理 编辑本段 Hugo Schiff 在1864年首次描述通过两个等物质的量的醛和胺的缩合反应形成Schiff base(希夫碱),距今已140年,其反应机理是:由含羰基的醛、酮类化合物与一级胺类化合物进行亲核加成反应,亲核试剂为胺类化合物,其化合物结构中带有孤电子对的氮原子进攻羰基基团上带有正电荷的碳原子,完成亲核加成反应,形成中间物α-羟基胺类化合物,然后进一步脱水形成Schiff base。 席夫碱的用途 编辑本段 由于席夫碱类化合物具有一定的药理学和生理学活性, 今年来一直是引人注目的研究对象。席夫碱化合物具有很好的抗菌、抗真菌作用。例如金黄色葡萄球菌, 革兰氏阳性菌、枯草杆菌, 革兰氏阳性菌、大肠杆菌,革兰氏阴性菌, 其杀菌率达到以上, 对新型隐球菌和白色念珠球菌也有很好的抑制作用。同时, 这些化合物均对超氧阳离子自由基有较好的抑制。席夫碱类化合物及其配合物具有抗结核、抗癌、抗菌等药理作用, 且其生物活性和金属的配合有关, 广泛应用于治疗、合成、生化反应等方向。今年来研究席夫碱配合物, 不仅讲究选择功能性原料, 并对其形成机理、光谱性质等方面有进一步的研究, 而且综合考虑形成配合物后的广谱性、功能性。席夫碱基团通过碳一氮双键一毛一上的氮原子与相邻的具有孤对电子的氧、硫、磷原子作为给体与金属原子配对。由于席夫碱配合物的广谱作用, 故关于这类化合物的研究是半个世纪以来生物无机领域的研究热点。研究金属离子和席夫碱配体之间的合成、结构、相互作用, 对于深入考察其生理、药理活性的作用机理、构造、稳定性等方面有着十分重要的作用。 参考资料 编辑本段 【1】南光明,刘德蓉.浅述希夫碱及其金属配合物的由来、产生机理、合成方法及展望.伊犁师范学院学报.2005,(3):58-59 【2】罗斌.席夫碱的合成及其金属配合物的合成与表征.化学工程与装备.2008,(10):45-49 Schiff's base 也称西佛碱

新型席夫碱锌配合物的合成及其在染料敏化太阳能电池中的应用

Vol .27 高等学校化学学报No .22006年2月 CHE M I CAL JOURNAL OF CH I N ESE UN I V ERSI TI ES 204~207 新型席夫碱锌配合物的合成及其在染料敏化 太阳能电池中的应用 夏江滨1,杨 红2,李富友2,黄春辉1,2 (1.北京大学稀土材料化学及应用国家重点实验室,北京100871;2.复旦大学先进材料实验室,上海200433)摘要 合成了新型席夫碱配体及其锌配合物,并利用核磁共振氢谱、紫外2可见吸收光谱和荧光光谱等方法对配体及其配合物进行了表征.将席夫碱及其锌的配合物作为光敏剂应用在染料敏化纳米薄膜太阳能电池中,配合物染料比席夫碱配体的光电转化效果更好,能量转化效率为1145%(AM 115,100mW ?c m -2). 关键词 席夫碱配体;锌配合物;光电转换效率 中图分类号 O614 文献标识码 A 文章编号 025120790(2006)022******* 收稿日期:2005203224. 基金项目:国家“八六三”计划项目(批准号:2002AA302403)、国家自然科学基金(批准号:20490210)和上海市科学技术委员会基金(批准号:03QB14006和03DJ14004)资助. 联系人简介:李富友(1973年出生),男,博士,副教授,从事光电功能材料研究.E 2mail:fyli@fudan .edu .cn 对于染料敏化纳米薄膜太阳能电池的光敏化作用,钌联吡啶配合物是目前最有效的敏化剂[1~3] ,因为它们具有较宽的可见吸收光谱、理想的氧化还原性质以及高的氧化态稳定性.但因为钌配合物价 格昂贵,人们对其它价格便宜的金属配合物进行了探索,常见的如铁[4]、铜[5]、锌[6]等过渡金属配合 物.1998年,Ferrere 等报道[4]了第一个铁的配合物Fe (L )2(CN )2(L =4,4′2二羧酸22,22联吡啶)在二 氧化钛纳米晶电极上的敏化效果:短路光电流为0129mA ?c m -2,开路光电压为360mV,尽管短路光 电流和开路光电压的值都很低,但由于铁的价格是钌的1%,该染料也被人们寄予希望.Deng 等[7]研 究了镓酞菁磺酸盐和锌卟啉磺酸盐的共敏化作用,发现当二者按适当比例混合后,镓酞菁磺酸盐的Q 带的光电转化显著加强. 最近,Nazeeruddin 等[8]报道了锌卟啉配合物,其光电转换效率达到4111%.近年来,席夫碱类配 体及其配合物由于在合成、催化等领域具有很广泛的应用而引起了人们的关注.本文设计合成了一种席夫碱及其锌的配合物,并研究了它们在二氧化钛纳米晶电极上的光电转化性质.1 实验部分 1.1 试剂与仪器 导电玻璃CT O (15Ω/c m 2)在可见光区的透过率大于80%,由GE 公司提供;异丙氧钛、碳酸丙烯 酯(PC )、3,42二氨基苯甲酸、42二乙基氨基水杨醛和42叔丁基吡啶均为Acr os 公司产品.其它试剂均为分析纯.Ru (L )2(NCS )2(L =4,4′2二羧酸22,22联吡啶)(简称N3)染料购自瑞士Solar onix 公司.氧化还原电解质为015mol/L L iI +0105mol/L I 2+011mol/L 42 叔丁基吡啶(溶剂为PC 和乙氰的混合物,体积比为1∶1). C,H 和N 元素分析在意大利Carbo Erba 1106全自动元素分析仪上测定;核磁共振氢谱在B ruker ARX500核磁共振仪上测定;染料在溶液中及在Ti O 2膜上的吸收光谱用岛津UV 23500紫外2可见光谱仪 记录;荧光光谱用H itachi F 24500荧光光谱仪测试.照射光源为100mW ?c m -2的氙灯(O riel,US A ), 在光路上放置AM 0和AM 115的滤光片,得到AM 115的模拟太阳光.并根据需要,在光路中放置一 定组合的Schott 的干涉滤光片,获得一定波长的单色光.电极的有效受光面积为01188c m 2.CT O 导电 玻璃的透射与反射损失不做校正.电池的I 2V 曲线由计算机控制的Keithley 2400数字源表得到.

席夫碱的研究进展

席夫碱的研究进展 1席夫碱的简单介绍 1.1席夫碱定义 席夫碱主要是指含有亚胺或甲亚胺特性基团(-RC=N-)的一类有机化合 物,通常席夫碱是由胺和活性羰基缩合而成。席夫碱类化合物及其金属配合 物主要在药学、催化、分析化学、腐蚀以及光致变色领域的重要应用。在医 学领域,席夫碱具有抑菌、杀菌、抗肿瘤、抗病毒的生物活性;在催化领域, 席夫碱的钴、镍和钯的配合物已经作为催化剂使用;在分析化学领域,席夫 碱作为良好配体,可以用来鉴别、鉴定金属离子和定量分析金属离子的含量 [ 1];在腐蚀领域,某些芳香族的席夫碱经常作为铜的缓蚀剂[ 2];在光致变 色领域,某些含有特性基团的席夫碱也具有独特的应用[ 3] 。 R2C=O + R'NH2 →R2C=NR' + H2O 席夫碱的制备在催化下反应,但是不能用强酸,因为氢离子和羰基结合 成珜盐而增加羰基的亲电性能,但亲离子和氨基结合后形成铵离子的衍生物, 丧失了胺的亲核能力,所以本类反应条件要求非常严格。席夫碱类化合物的 C=N基团中杂化轨道的N原子具有易于流动的二维平面孤对电子,能够有效 配位金属离子和中性小分子,使席夫碱成为配位化学研究的重要的配体。 1.2席夫碱的种类 1.2.1按配体结构 按配体结构分:单席夫碱、双席夫碱、大环席夫碱。单希夫碱合成采用单胺类和单羰基化合物的缩合。这类希夫碱化合物的结构形式如图1所 示[ 4]。双希夫碱多采用二胺和羰基化合物反应制备得到这类配体的结构如 图2所示。大环希夫碱在合成中经常采用碱土金属阳离子或镧系金属作为 模板试剂,形成(1 + 1) 、(2十2) 、(3 + 3)型大环希夫碱,结构如图3所 示:( a) 、( b) 、( c)分别对应所 1 + l,2 + 2和3十3型大环希夫碱。 图1单席夫碱图2双席夫碱图3大环席夫碱 1.2.2按缩合物质不同 按缩合物质不同可分为缩胺类希夫碱、缩酮类希夫碱等。希夫碱的早期研究为缩胺类,后来发展为缩酮类、缩胺类、缩氨基脲类、胍类、氨基酸类及氨基酸酯类[ 4]。

席夫碱

席夫碱 席夫碱主要是指含有亚胺或甲亚胺特性基团(-RC=N-)的一类有机化合物,通常席夫碱是由胺和活性羰基缩合而成。席夫碱类化合物及其金属配合物主要在药学、催化、分析化学、腐蚀以及光致变色领域的重要应用。在医学领域,席夫碱具有抑菌、杀菌、抗肿瘤、抗病毒的生物活性[ 1];在催化领域,席夫碱的钴、镍和钯的配合物已经作为催化剂使用[ 2];在分析化学领域,席夫碱作为良好配体,可以用来鉴别、鉴定金属离子和定量分析金属离子的含量[ 3];在腐蚀领域,某些芳香族的席夫碱经常作为铜的缓蚀剂[ 4];在光致变色领域,某些含有特性基团的席夫碱也具有独特的应用[ 5]。 合成方法 Schiff碱稀土配合物的合成方法主要有直接合成法和分步合成法,(该把直接合成法和分步合成法介绍一下)分步合成法得到的产品无论是在(产品)产率上,还是在(产品)纯度上都较直接合成法理想。当反应活性低或选择性不好,用前述两种方法合成的产物不稳定或者产率低时,可选用模板合成法。所谓模板合成法就是将金属离子作为模板试剂加入到羰基化合物中与胺类化合物反应的一类合成方法。如(在)合成二羰基化合物和多胺的Schiff碱配体及其配合物时多采用此方法。当合成的Schiff碱在反应溶剂中溶解度很小,上述三种合成方法均不适用时,一般采用逐滴反应法,即向胺类化合物与金属离子的混合溶液中逐滴活泼碳基化合物溶液的一种方法[ 6]。这些合成方法适用于不同类型的Schiff碱金属配合物,它们各有优缺点。大多数氨基酸Schiff碱稀土配合物的制备均可采用分步合成法。(但分步合成法是制备氨基酸Schiff碱稀土配合物最常用的一种方法)催化领域的应用 席夫碱及其配合物在催化领域的应用也很广泛,概括起来说,席夫碱做催化剂主要应用于聚合反应、不对称催化环丙烷化反应以及烯烃催化氧化方面和电催化领域等。 魏丹毅[ 7]等合成了9种稀土元素(La,Pr,Nd,Sm,Gd,Tb,Er,Yb,Y)与水杨醛-缩β-丙氨酸(H2L)的双核配合物,发现此配合物对甲基丙烯酸甲酯(MMA)的聚合反应有催化活性;姚克敏[ 8]等用直链醚-脂肪族氨基酸新型Schiff碱作为综合配体与稀土离子配位,发现它们在甲基丙烯酸甲酯聚合中有较好的催化活性;Yong [ 9]等发现钛席夫碱配合物对乙烯、苯乙烯的聚合反应有很好的催化活性. 近年来,不对称催化环丙烷化反应已经成为研究的热焦点,在其催化剂体系中铜的席夫碱配合物是被研究最早最深人的体系之一。Cai[ 10]等用氨基醇合成了双核席夫碱配合物,用于催化反应,顺式产物与反式产物最好结果比为1/3,顺式产物的收率为87%,反式产物的收率为93%;仇敏[ 11]等用制备的系列??取代

芹菜素席夫碱金属配合物的合成及抗氧化活性研究

芹菜素席夫碱金属配合物的合成及抗氧化活性研究 李海霞,文丽君,陈丽珍,翟锐锐,艾朝辉,李鹃,蔡蓝杰 (海南医学院药学院,海南海口 571199) 摘要:芹菜素(AP)是一种天然的抗氧化剂,具有多种生物活性,但是存在药效低、开发利用低等问题。为了提高芹菜素的开发应用和药效,本研究对芹菜素进行结构修饰,制备了芹菜素席夫碱金属衍生物,并采用紫外(UV ),红外(UV ),差热-热重分析(DSC-DTG )等波谱分析方法表征化合物。采用水杨酸法和邻苯三酚-NBT 法评价芹菜素和其衍生物的体外清除羟基自由基(·OH )和超氧自由基(O 2-·)活性。通过表征,合成了两种新的芹菜素席夫碱金属配合物,即[Co(C 22H 16O 4N)2(H 2O)2]·8H 2O 和[Zn(C 22H 16O 4N)2(H 2O)2]·4H 2O 配合物,AP 、[CoL 2]和[ZnL 2]清除·OH 自由基的IC 50为880.65±46.52 μg/mL ,517.12±16.36 μg/mL ,633.62±18.95 μg/mL ;清除O 2-·自由基的IC 50为116.30±3.94 μg/mL ,61.13±0.05 μg/mL ,48.56±0.32 μg/mL ,合成的配合物相对芹菜素抗氧化活性增强,有望开发出一种新型抗氧化性食品添加剂,为芹菜素的开发及抗氧化剂的研究提供理论研究基础。 关键词:芹菜素;配合物;超氧自由基清除能力;羟基自由基清除能力 文章篇号:1673-9078(2016)07-164-169 DOI: 10.13982/j.mfst.1673-9078.2016.7.026 Synthesis of Schiff Base Metal Derivatives of Apigenin and Their Antioxidant Activity LI Hai-xia, WEN Li-jun, CHEN Li-zhen, ZHAI Rui-rui, AI Zhao-hui, LI Juan, CAI Lan-jie (College of Pharmacy, Hainan Medical College, Haikou 571199, China) Abstract: Apigenin (AP) is a natural antioxidant possessing multiple biological activities, but has some limitations such as low efficacy and low utilization. To better develop and utilize AP , its structure was modified. The Schiff-base derivatives of AP ([Co(C 22H 16O 4N)2(H 2O)2]·8H 2O and [Zn(C 22H 16O 4N)2(H 2O)2]·4H 2O) were synthesized, and characterized by ultraviolet (UV), infrared (IR), differential scanning calorimetry (DSC)-derivative thermograms (DTG), and other spectroscopic methods. Through the salicylic acid method and the pyrogallic acid-nitroblue tetrazolium (NBT) method, the in vitro superoxide radical and hydroxyl radical scavenging activities of AP and its Schiff-base derivatives were evaluated. Structural characterization showed that two Schiff-base derivatives of AP , [Co(C 22H 16O 4N)2(H 2O)2]·8H 2O and [Zn(C 22H 16O 4N)2(H 2O)2]·4H 2O, were successfully prepared. The half-maximal inhibitory concentration (IC 50) values of AP , [CoL 2], and [ZnL 2] on scavenging hydroxyl radical were 880.65 ± 46.52 μg/mL, 517.12 ± 16.36 μg/mL, and 633.62 ± 18.95 μg/mL, respectively. The IC 50 values of AP , [CoL 2], and [ZnL 2] on scavenging superoxide radical were 116.30 ± 3.94 μg/mL, 61.13 ± 0.05 μg/mL, and 48.56 ± 0.32 μg/mL, respectively. Two novel Schiff-base complexes of AP , [Co(C 22H 16O 4N)2(H 2O)2]·8H 2O and [Zn(C 22H 16O 4N)2(H 2O)2]·4H 2O, possessed stronger antioxidant activity than AP , which might be a new antioxidant food additive. This research provided a theoretical basis for AP development during future studies on antioxidants. Key words: apigenin; complexes; superoxide radical scavenging ability; hydroxyl radical scavenging ability 抗氧化活性已被证实在保护人类抗击许多致命疾病和延缓衰老方面发挥着重要的作用,活性氧(Reactive Oxygen Species ,ROS)主要包括:超氧阴离 164 收稿日期:2015-09-14 基金项目:海南省自然科学基金(214032);海南医学院大学生创新训练项目(HYCX2014034) 作者简介:李海霞(1979-),女,副教授,研究方向:天然产物开发及配合物药物研究 通讯作者:文丽君(1975-),女,副教授,研究方向:有机合成及配合物药物研究 子自由基、羟基自由基及有机过氧化物自由基等,肿 瘤、冠心病和衰老均与自由基引起的膜脂质氧化性损伤有关。天然抗氧化剂在稳定性、膜穿透性、生物利用度、免疫原性和价格等方面有一些限制,所以研究能够清除自由基的替代物,如:小分子金属配合物,具有非常重要的意义[1~2]。芹菜素(Apigenin )属于黄酮类化合物,是一种天然的抗氧化剂,具有抗菌、抗氧化、抗癌、抗炎、止痒等生物活性[3~5]。黄酮类化合物是普遍存在于植物中的天然多酚类化合物,是人类饮食的重要成分。超过6000种黄酮类化合物已被研究,

相关文档
最新文档